BioServe - A REPROCELL Company
Dr. Bhawna Dubey's work experience includes serving as the Chief Scientific Officer at BioServe - A Reprocell Company since March 2021. Prior to this role, they worked as a Scientist at ATS GeneTech Pvt Ltd from April 2018 to August 2020. Dr. Bhawna also served as a Research Associate volunteer at the Fox Chase Cancer Center from June 2014 to April 2018. Dr. Dubey was a Postdoctoral Research Associate at the Centre for Cellular and Molecular Biology from September 2010 to January 2012 and a Doctoral Research Fellow at the Central Forensic Science Laboratory from August 2006 to August 2010. Dr. Bhawna started their professional career as a Lecture at St. Aloysius College, Jabalpur from May 2005 to August 2006.
Dr. Bhawna Dubey obtained their PhD in Science from Jadavpur University, completing their studies from 2006 to 2010. Prior to that, they earned a Master of Science (MSc) in Microbiology, General from Rani Durgavati Vishwavidyalaya between 2000 and 2004.
This person is not in any teams
This person is not in any offices
BioServe - A REPROCELL Company
Bioserve is a dynamic organization primarily centred on clinical diagnostics solutions to answer vital questions about an early Cancer diagnosis. We are India's leading oligosynthesis service provider and have diversified further to Molecular services like DNA/RNA sequencing, utilizing the classic Sanger platforms, as well as the highly advanced Next-Generation sequencing platforms. Bioserve's core expertise in global biorepository provides leading academic and industry researchers with access to over 600,000 human DNA, tissue, and serum samples linked to detailed clinical and demographic data from 120,000 consented and anonymized patients across four continents. Utilizing BioServe's preclinical molecular services, researchers can identify genetic markers, validate drug targets, and correlate clinical and molecular data to accelerate the development of new and safer drugs. BioServe's research division offers everything from from nucleic acids processing, DNA synthesis, high throughput sequencing and genotyping, genome wide-scans and gene expression analysis to ready-made large epidemiologically sound case-control studies. BioServe's customers include nearly every major government research institution, clinical diagnostic labs, hospitals and pharmaceutical company. With 20+ years of excellence in offering quality services, BioServe has recently been acquired by the Reprocell Group, headquartered in Japan with corporate offices in Europe, USA, and India.